Explore
13D/13G Activist Filings
118,703 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | PARK | Park Dental Partners, Inc. | AO Partners I, LP | 13G | 1.5% | 62K |
| Feb 17, 2026 | MREO | Mereo BioPharma Group plc | Northpond Ventures, LP | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | FOUR | Shift4 Payments, Inc. | Jared Isaacman | 13G/A | 25.2% | 22.4M |
| Feb 17, 2026 | BOLD | BOUNDLESS BIO, INC. | Nextech VI GP S.a. r.l. | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | WHD | Cactus, Inc. | Cactus WH Enterprises. LLC | 13G/A | 12.1% | 9.7M |
| Feb 17, 2026 | ETHZ | ETHZilla Corporation | FF Consumer Growth II, LP | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | MYFW | First Western Financial Inc | Banc Fund IX L.P. | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | WLTH | WEALTHFRONT CORPORATION | DAG Ventures Management IV, LLC | 13G | 9.4% | 13.8M |
| Feb 17, 2026 | BRZE | BRAZE, INC. | Battery Ventures XI-A, L.P. | 13G/A | 0.7% | 715K |
| Feb 17, 2026 | TTAN | SERVICETITAN, INC. | Battery Ventures XI-A, L.P. | 13G/A | 1.5% | 1.2M |
| Feb 17, 2026 | QURE | uniQure N.V. | EcoR1 Capital, LLC | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | VTGN | Vistagen Therapeutics, Inc. | ORBIMED ADVISORS LLC | 13G/A | 3.6% | 1.4M |
| Feb 17, 2026 | IVA | Inventiva S.A. | Andera Partners | 13G/A | 7.7% | 14.1M |
| Feb 17, 2026 | SIBN | SI-BONE, Inc. | OrbiMed Capital LLC | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | TNGX | Tango Therapeutics, Inc. | EcoR1 Capital, LLC | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | NSPR | InspireMD, Inc. | ORBIMED ADVISORS LLC | 13G | 7.4% | 3.1M |
| Feb 17, 2026 | MKTW | MarketWise, Inc. | Monument & Cathedral Holdings, LLC | 13D/A | 74.3% | 7.0M |
| Feb 17, 2026 | NN | NextNav Inc. | OSI Capital Management LLC | 13G/A | 9.8% | 13.3M |
| Feb 17, 2026 | XNCR | Xencor Inc | EcoR1 Capital, LLC | 13G/A | 6.4% | 4.6M |
| Feb 17, 2026 | CTMX | CytomX Therapeutics, Inc. | OrbiMed Advisors LLC | 13G/A | 2.1% | 3.5M |
| Feb 17, 2026 | ISTR | Investar Holding Corp | Banc Fund IX L.P. | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | BIOA | BioAge Labs, Inc. | ADAR1 Capital Management, LLC | 13G/A | 0.4% | 136K |
| Feb 17, 2026 | VOR | VOR BIOPHARMA INC. | Venrock Healthcare Capital Partners III, L.P. | 13G/A | 9.9% | 2.2M |
| Feb 17, 2026 | IKT | Inhibikase Therapeutics, Inc. | ADAR1 Capital Management, LLC | 13G/A | 9.9% | 12.5M |
| Feb 17, 2026 | VYGR | Voyager Therapeutics, Inc. | EcoR1 Capital, LLC | 13G/A | 6.8% | 4.0M |
| Feb 17, 2026 | IBIO | iBio, Inc. | ADAR1 Capital Management, LLC | 13G/A | 4.4% | 1.4M |
| Feb 17, 2026 | N/A | Cybin Inc. | ORBIMED ADVISORS LLC | 13G | 2.8% | 1.4M |
| Feb 17, 2026 | EQH | Equitable Holdings, Inc. | Canada Pension Plan Investment Board | 13G/A | 6.7% | 19.3M |
| Feb 17, 2026 | ALMU | Aeluma, Inc. | Mark N. Tompkins | 13G/A | 11.3% | 2.0M |
| Feb 17, 2026 | NXTC | NextCure, Inc. | Ikarian Capital, LLC | 13G | 10.0% | 363K |
| Feb 17, 2026 | NKLR | GSR III Acquisition Corp. | Merus Global Investments, LLC | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | ORBS | Eightco Holdings Inc. | CF Series DAT A LP | 13G/A | 3.1% | 6.2M |
| Feb 17, 2026 | BACQ | Inflection Point Acquisition Corp. IV | Merus Global Investments, LLC | 13G/A | 6.9% | 1.7M |
| Feb 17, 2026 | NTIP | NETWORK-1 TECHNOLOGIES, INC. | CANNELL CAPITAL LLC | 13G | 5.0% | 1.1M |
| Feb 17, 2026 | STRA | STRATEGIC EDUCATION INC | Marshfield Associates Inc | 13G/A | 6.3% | 1.5M |
| Feb 17, 2026 | SVIIF | Spring Valley Acquisition Corp. II | Merus Global Investments, LLC | 13G/A | 7.2% | 708K |
| Feb 17, 2026 | TEN | TSAKOS ENERGY NAVIGATION LTD | CastleKnight Master Fund LP | 13G/A | 4.1% | 1.2M |
| Feb 17, 2026 | AIV | Apartment Investment and Management Company | Silver Point Capital, L.P. | 13G | 1.2% | 1.8M |
| Feb 17, 2026 | GCTK | Glucotrack, Inc. | Ikarian Capital, LLC | 13G | 4.5% | 46K |
| Feb 17, 2026 | N/A | Copper Property CTL Pass Through Trust | Silver Point Capital, L.P. | 13G/A | 12.9% | 9.7M |
| Feb 17, 2026 | OMDA | Omada Health, Inc. | Andreessen Horowitz Fund IV, L.P. | 13G/A | 5.5% | 3.2M |
| Feb 17, 2026 | CNTB | Connect Biopharma Holdings Limited | Ikarian Capital, LLC | 13G | 8.8% | 4.9M |
| Feb 17, 2026 | N/A | Smart Share Global Limited | Silver Point Capital, L.P. | 13G/A | 11.4% | 49.3M |
| Feb 17, 2026 | LXU | LSB Industries, Inc. | CastleKnight Master Fund LP | 13G/A | 4.5% | 3.2M |
| Feb 17, 2026 | NAVN | NAVAN, INC. | AH Parallel Fund V, L.P. | 13G | 4.5% | 10.4M |
| Feb 17, 2026 | SHC | Sotera Health Co | Sessa Capital (Master), L.P. | 13G | 5.6% | 15.9M |
| Feb 17, 2026 | ASPI | ASP Isotopes Inc. | Mann Paul Elliot | 13G/A | 7.0% | 7.8M |
| Feb 17, 2026 | MDRX | Veradigm Inc. | Silver Point Capital, L.P. | 13G/A | 6.3% | 6.8M |
| Feb 17, 2026 | MDGL | Madrigal Pharmaceuticals, Inc. | PAULSON & CO. INC. | 13G/A | 7.5% | 1.7M |
| Feb 17, 2026 | VIK | Viking Holdings Ltd. | Canada Pension Plan Investment Board | 13G/A | 6.4% | 20.1M |